By: IPP Bureau
Last updated : February 05, 2022 1:15 pm
Mangalam Drugs and Organics Limited has reported standalone financial results for the period ended December 31, 2021
Financial Results (Q3 FY2022) - QoQ comparison
The company has reported total income of Rs. 101.8784 crore during the period ended December 31, 2021 as compared to Rs. 123.0233 crore during the period ended September 30, 2021.
The company has posted net profit of Rs. 4.0222 crore for the period ended December 31, 2021 as against net profit of Rs. 4.5281 crore for the period ended September 30, 2021.
Financial Results (Q3 FY2022) - YoY comparison
The company has reported total income of Rs. 101.8784 crore during the period ended December 31, 2021 as compared to Rs.89.9551 crore during the period ended December 31, 2020.
The company has posted a net profit of Rs.4.0222 crore for the period ended December 31, 2021 as against a net profit of Rs.6.4342 crore for the period ended December 31, 2020.
Financial Results (nine-month ended FY2022) - YoY comparison
The company has reported total income of Rs.330.2024 crore during the nine-month period ended December 31, 2021 as compared to Rs.291.9604 crore during the nine-month period ended December 31, 2020.
The company has posted net profit of Rs.12.9660 crore for the nine-month period ended December 31, 2021 as against a net profit of Rs.25.8167 crore for the nine-month period ended December 31, 2020.